RNLX
Income statement / Annual
Last year (2024), Renalytix Plc's total revenue was $2.29 M,
a decrease of 32.74% from the previous year.
In 2024, Renalytix Plc's net income was -$33.46 M.
See Renalytix Plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
| Operating Revenue |
$2.29 M |
$3.40 M |
$2.97 M |
$1.49 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$2.13 M
|
$2.70 M
|
$2.05 M
|
$804.00 K
|
$74.00 K
|
$30.99 K
|
$0.00
|
| Gross Profit |
$156.00 K
|
$701.00 K
|
$918.00 K
|
$687.00 K
|
-$74.00 K
|
-$30.99 K
|
$0.00
|
| Gross Profit Ratio |
0.07
|
0.21
|
0.31
|
0.46
|
0
|
0
|
0
|
| Research and Development Expenses |
$9.29 M
|
$14.30 M
|
$14.65 M
|
$10.04 M
|
$4.57 M
|
$39.60 M
|
$0.00
|
| General & Administrative Expenses |
$19.75 M
|
$43.06 M
|
$12.95 M
|
$8.37 M
|
$11.08 M
|
$6.54 M
|
$1.25 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$836.00 K
|
| Selling, General & Administrative Expenses |
$19.75 M
|
$43.06 M
|
$12.95 M
|
$8.37 M
|
$11.08 M
|
$6.54 M
|
$418.00 K
|
| Other Expenses |
$0.00
|
$656.00 K
|
$30.69 M
|
$14.88 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$29.04 M
|
$43.06 M
|
$58.29 M
|
$33.30 M
|
$11.08 M
|
$6.54 M
|
$418.00 K
|
| Cost And Expenses |
$31.17 M
|
$45.76 M
|
$60.34 M
|
$34.10 M
|
$11.08 M
|
$6.54 M
|
$418.00 K
|
| Interest Income |
$0.00
|
$509.00 K
|
$12.00 K
|
$236.00 K
|
$530.00 K
|
$39.00 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$2.00 K
|
$3.00 K
|
$2.00 K
|
$20.00 K
|
$0.00
|
| Depreciation & Amortization |
$364.00 K
|
$508.00 K
|
$489.00 K
|
$282.00 K
|
$74.00 K
|
$31.00 K
|
$1.25 M
|
| EBITDA |
-$29.61 M |
-$41.71 M |
-$52.69 M |
-$33.69 M |
-$11.08 M |
-$5.37 M |
-$418.00 K |
| EBITDA Ratio |
-12.93
|
-12.26
|
-17.74
|
-22.59
|
0
|
0
|
0
|
| Operating Income Ratio |
-12.93
|
-12.45
|
-19.32
|
-21.87
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$3.84 M
|
-$3.38 M
|
$7.93 M
|
-$2.11 M
|
-$295.00 K
|
$535.00 K
|
$0.00
|
| Income Before Tax |
-$33.45 M
|
-$46.22 M
|
-$49.63 M
|
-$35.79 M
|
-$10.61 M
|
-$6.52 M
|
-$418.00 K
|
| Income Before Tax Ratio |
-14.61
|
-13.58
|
-16.71
|
-24
|
0
|
0
|
0
|
| Income Tax Expense |
$4.00 K
|
$2.00 K
|
$25.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$33.46 M
|
-$45.61 M
|
-$45.28 M
|
-$34.73 M
|
-$9.84 M
|
-$42.30 M
|
-$1.25 M
|
| Net Income Ratio |
-14.62
|
-13.4
|
-15.24
|
-23.29
|
0
|
0
|
0
|
| EPS |
-0.62 |
-1.1 |
-1.24 |
-0.98 |
-0.34 |
-1.98 |
-0.06 |
| EPS Diluted |
-0.62 |
-1.1 |
-1.34 |
-0.98 |
-0.34 |
-1.98 |
-0.06 |
| Weighted Average Shares Out |
$54.09 M
|
$41.11 M
|
$33.99 M
|
$35.43 M
|
$28.95 M
|
$21.28 M
|
$20.90 M
|
| Weighted Average Shares Out Diluted |
$54.09 M
|
$41.11 M
|
$36.92 M
|
$35.74 M
|
$29.54 M
|
$21.28 M
|
$20.90 M
|
| Link |
|
|
|
|
|
|
|
